Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

AEterna codevelopment agreement for AE-941

Feb. 27, 1997

Bio-Technology General grants license to BioLon in Japan

Feb. 26, 1997

Comparative trial of dorzolamide and acetazolamide

Feb. 21, 1997

Alcon describes dihydropyridines for ocular use

Feb. 21, 1997

U.K. launch for P&U glaucoma Rx

Feb. 19, 1997

Gene causing glaucoma located and cloned

Feb. 3, 1997

NYU seeks partner for novel antibacterial technology

Jan. 22, 1997

Olopatadine studied for allergic conjunctivitis

Jan. 20, 1997

Acular approved in U.S. for postoperative ocular inflammation

Jan. 7, 1997

Ciprofloxacin ophthalmic solution effective in treating bacterial corneal ulcers

Jan. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.